Christopher P. Leamon

Christopher P. Leamon has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Endocyte Inc and Fusion Pharmaceuticals Inc. Over a trading history stretching from 4 February 2016 to 4 June 2024, the count stands at 39 filings.

No open-market purchase appears, only 9 sales worth €900k. Besides market trades, the filings include 12 share grants and 12 option exercises.

The record was last updated on 4 June 2024 with a transaction in Fusion Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.